Clinical Trial Update: Naloxone HCl PR Tablets in Patients With Opioid Induced Constipation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Naloxone HCl PR tablets targeting opioid-induced constipation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• Naloxone HCl PR tablets (naloxone hydrochloride)

Snippet

Sponsor: Develco Pharma Schweiz AG | Conditions: Opioid-Induced Constipation | Phase 3 | Status: UNKNOWN